Mineralys Therapeutics (MLYS) Other Non-Current Assets (2022 - 2026)
Quarterly results put Other Non-Current Assets at $360000.0 for Q1 2026, down 9.32% from a year ago — trailing twelve months through Mar 2026 was $360000.0 (down 9.32% YoY), and the annual figure for FY2025 was $382000.0, down 23.45%.
Mineralys Therapeutics has reported Other Non-Current Assets over the past 5 years, most recently at $360000.0 for Q1 2026.
- Other Non-Current Assets reached $360000.0 in Q1 2026 per MLYS's latest filing, down from $382000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.6 million in Q4 2022 and bottomed at $39000.0 in Q1 2023.
- Median Other Non-Current Assets over the past 5 years was $380500.0 (2024), compared with a mean of $379857.1.
- The largest annual shift saw Other Non-Current Assets tumbled 96.87% in 2023 before it skyrocketed 878.43% in 2024.
- Over 5 years, Other Non-Current Assets stood at $1.6 million in 2022, then crashed by 96.87% to $51000.0 in 2023, then surged by 878.43% to $499000.0 in 2024, then fell by 23.45% to $382000.0 in 2025, then dropped by 5.76% to $360000.0 in 2026.
- Business Quant data shows Other Non-Current Assets for MLYS at $360000.0 in Q1 2026, $382000.0 in Q4 2025, and $144000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.13 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | 360,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 360,000.00 |
| Dec 31, 2025 | 382,000.00 |
| Sep 30, 2025 | 144,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Mar 31, 2025 | 397,000.00 |
| Dec 31, 2024 | 499,000.00 |
| Sep 30, 2024 | 452,000.00 |
| Jun 30, 2024 | 449,000.00 |
| Mar 31, 2024 | 379,000.00 |
| Dec 31, 2023 | 51,000.00 |
| Sep 30, 2023 | 51,000.00 |
| Jun 30, 2023 | 51,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 1.63 Mn |